Kayexalate and Baby aspirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Kayexalate and Baby aspirin together.

The phase IV clinical study analyzes what interactions people who take Kayexalate and Baby aspirin have. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 16, 2022

5 people who take Kayexalate and Baby aspirin together, and have interactions are studied.


What is Kayexalate?

Kayexalate has active ingredients of sodium polystyrene sulfonate. eHealthMe is studying from 4,323 Kayexalate users for its effectiveness, alternative drugs and more.

What is Baby aspirin?

Baby aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 23,960 Baby aspirin users for its effectiveness, alternative drugs and more.

Number of Kayexalate and Baby aspirin reports submitted per year:

Kayexalate and Baby aspirin drug interactions.

Common Kayexalate and Baby Aspirin drug interactions by gender *:

female:

  1. Arthritis
  2. Asthenia
  3. Bone pain
  4. Bronchitis
  5. Cardiac disorder
  6. Chest pain
  7. Coronary artery disease
  8. Cough
  9. Dyslipidaemia
  10. Dyspnoea

male:

  1. Anaemia
  2. Blood glucose decreased
  3. Blood glucose increased
  4. Epistaxis
  5. Glycosylated haemoglobin increased
  6. Hyperkalaemia
  7. Thrombocytopenia

Common Kayexalate and Baby Aspirin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiac failure congestive
  2. Angina pectoris
  3. Ankle fracture
  4. Arthritis
  5. Asthenia
  6. Bone pain
  7. Bronchitis
  8. Cardiac disorder
  9. Chest pain
  10. Coronary artery disease

50-59:

n/a

60+:

  1. Abdominal discomfort
  2. Angina pectoris
  3. Chest pain
  4. Coronary artery disease
  5. Cough
  6. Dyslipidaemia
  7. Dyspnoea
  8. Fall
  9. Femur fracture
  10. Gastrooesophageal reflux disease

* Approximation only. Some reports may have incomplete information.

Do you take Kayexalate and Baby aspirin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Kayexalate and Baby aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Kayexalate interactions:

Browse all interactions between Kayexalate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Baby aspirin interactions:

Browse all interactions between Baby aspirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sodium polystyrene sulfonate and aspirin (the active ingredients of Kayexalate and Baby aspirin, respectively), and Kayexalate and Baby aspirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Kayexalate and Baby aspirin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: